Navigation Links
Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Date:11/2/2007

University of Florida, Gainesville, and a lead investigator in this Phase IIb study.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and a leading cause of cirrhosis, liver cancer and the need for liver transplants. According to the Centers for Disease Control and Prevention (CDC), an estimated 4.1 million Americans (1.6 percent) have been infected with hepatitis C; 3.2 million are chronically infected. The number of new infections per year has declined from an average of 240,000 in the 1980s to about 26,000 in 2004. CDC estimates the number of hepatitis C-related deaths could increase to 38,000 annually by the year 2010, surpassing annual HIV/AIDS deaths.

About PEGASYS

PEGASYS, in combination with COPEGUS (ribavirin), are indicated for the treatment of adults with chronic hepatitis C who have compensated liver disease and have not previously been treated with interferon alpha. Efficacy has been demonstrated in patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are clinically stable (e.g., antiretroviral therapy not required or receiving stable antiretroviral therapy). In addition, PEGASYS in combination with COPEGUS is the first and only FDA-approved regimen for the treatment of chronic hepatitis C in patients coinfected with hepatitis C and HIV. PEGASYS is the only pegylated interferon indicated for the treatment of adult patients with chronic hepatitis B (HBeAg positive and HBeAg negative chronic hepatitis B who have compensated liver disease and evidence of viral replication and liver inflammation).

PEGASYS is dosed at 180mcg as a subcutaneous injection taken once a week. COPEGUS is available as a 200mg tablet, and is administered orally two times a day as a split dose. Roche has backed PEGASYS with the most extensive clinical research program ever undertaken in hepatitis C, with major studies initiated to advance treat
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... April 24, 2015 Boston Scientific Corporation (NYSE: ... 40 th Annual Healthcare Conference on May 6 in ... , executive vice president and chief financial officer, and ... a 35-minute question and answer session regarding the company with ... A live webcast of the presentation and question and answer ...
(Date:4/24/2015)... , Apr. 24, 2015 Research ... has announced the addition of the ... Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End ... - Global Forecast to 2020" report ... laboratory accessories market is expected to reach ...
(Date:4/24/2015)... N.J. , April 24, 2015  Novartis Pharmaceuticals Corporation ... the second year in a row on the annual DiversityInc ... of its 2015 Top 50 Companies for Diversity on April ... NY . NPC also ranked second on the DiversityInc ... Top 10 Companies for Employee Resource Groups list. ...
Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4
... 2011 The American Pharmacists Association (APhA) ... Initiative, a coordinated approach to preventing cardiovascular disease and ... of Health and Human Services (HHS), the Centers for ... Medicaid Services (CMS), the initiative,s goal is to prevent ...
... 13, 2011 - ImpactRx, a Symphony Technology ... impact of promotion on physician prescribing behavior, announced today ... leading provider of insight into the drivers of physician ... highly complementary capabilities of the two companies into a ...
Cached Medicine Technology:American Pharmacists Association Partners with HHS, CDC and CMS in the Million Hearts Initiative 2American Pharmacists Association Partners with HHS, CDC and CMS in the Million Hearts Initiative 3American Pharmacists Association Partners with HHS, CDC and CMS in the Million Hearts Initiative 4ImpactRx Acquires TargetRx 2ImpactRx Acquires TargetRx 3
(Date:4/26/2015)... April 26, 2015 With the FCPX LUT ... X editors can quickly and easily add desaturated color ... contains a mathematical formula for modifying an image. The LUT ... the table. This pack comes with 60 black and white ... and contemporary black and white films. With the FCPX ...
(Date:4/26/2015)... A live auction will be held to ... surgery centers and other medical facilities around the United ... radiology, surgery, endoscopy, lab, anesthesia, exam and much more. ... April 28th starting at 10:00am EDT. The equipment is ... Hiatus Rd., Sunrise, FL 33351. Anyone can participate ...
(Date:4/26/2015)... This annual celebration is one of ... will include a spectacular collection of vendors offering distinctive ... and incense, chimes, vases, candleholders, fleece throws, trivets, jewelry ... unique collection of vendors, guests will have the opportunity ... the Jimmie Jazz Band. , “We are ecstatic ...
(Date:4/26/2015)... Forbes Living is scheduled to ... which is synonymous with clean beaches, sparkling office buildings, and ... major economic influencers in the city on the Pacific Coast ... are pleased to announce the show will be broadcast on ... PM PDT. Tune in to find out what the effervescent ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 MidSouth ... grow throughout the Southeast. MidSouth Pain Treatment Center is ... in Cordova, Southaven, Oxford and Jackson, two ambulatory surgery ... in the Southaven and Cordova locations. , Dr. ... ”I went into medicine to help people, and when ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:It’s Coming! The 5th Annual Tulip Festival & Mother’s Day Celebration at Honor's Haven Resort & Spa! 2Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Growing Pains for MidSouth Pain Treatment Center 2
... Philadelphia, PA, 6 May 2009 Obstructive sleep apnea ... decreased in heart failure (HF) patients managed with beta-blockers ... of Journal of Cardiac Failure ( http://www.elsevier.com/locate/cardfail ... Predictors of Sleep Apnea in Patients with Heart Failure ...
... - With more than ... breast or gynecologic cancers in 2008, Moffitt ... toward focusing more on personalized cancer care treatment ... of women,s oncology.(Photo: http://www.newscom.com/cgi-bin/prnh/20090506/NY11963 )To view ...
... 6 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corporation (Nasdaq: BJGP ) (,BMP Sunstone, ... -- Oppenheimer 3rd Annual China Dragon Call Conference, held ... Avenue in New York City. Management is currently, ... 8:30, am ET on Tuesday, May ...
... Hour After Heart Surgery, 45-Year-Old Sits Up in ICU and Writes Notes ... ... Chuck Besen was discharged from University Medical Center (UMC) after making medical ... a donor heart and then a kidney transplant on the same day ...
... Such As AstraZeneca,s Iressa and Roche,s Avastin Will Drive ... New Report from Decision Resources WALTHAM, Mass., May 6 ... and advisory firms focusing on pharmaceutical and healthcare issues, ... China will more than double by 2013, growing from ...
... Families Who Reinforce Lifelong Milk-Drinking Habits at Lower Risk ... gifts that moms pass on to their families, one ... about bone health and osteoporosis, according to the National ... is the theme of this year,s Osteoporosis Awareness ...
Cached Medicine News:Health News:Sleep apnea may not be closely linked to heart failure severity 2Health News:Video: Research in Women's Cancers Leading the Personalized Medicine Revolution 2Health News:Total Artificial Heart Patient 3rd in the World to Receive Dual Transplants 2Health News:Chinese Non-Small-Cell Lung Cancer Drug Market Will More Than Double by 2013 2Health News:Mothers Play a Powerful Role in Determining Strength of Daughters' Bones 2Health News:Mothers Play a Powerful Role in Determining Strength of Daughters' Bones 3Health News:Mothers Play a Powerful Role in Determining Strength of Daughters' Bones 4
The PerkinElmer LS 45 Luminescence spectrometer offers versatility, reliability and ease-of-use for routine analyses in an affordable package....
Spectra 2000 Digital Spectrophotometer is designed for quantitative and qualitative analysis in visible range from 320 nm to 1020 nm....
... 400 Series Spectrophotometer ... approach to UV-VIS instrumentation. ... are incorporated into a ... in features and performance ...
... Quebec Colony Counter allows the user to quickly ... models allows for digital counting or manual counting. ... standard lens increasing magnification to 3.0X. The adjustable ... be raised or lowered. The lens also rotates ...
Medicine Products: